Antineoplastics/methylprednisoloneNeutropenia: 12 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1802卷 / 1期

关键词：

D O I：

10.1007/s40278-020-77971-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：53 / 53

相关论文

共 50 条

[1] Antineoplastics/epirubicinHepatitis B virus reactivation: 12 case reports
Reactions Weekly, 2021, 1851 (1) : 49 - 49
[2] Antineoplastics/glucocorticoidsZygomycosis: 3 case reports
Reactions Weekly, 2012, 1412 (1) : 8 - 8
[3] Antineoplastics/pembrolizumabDeath: 2 case reports
Reactions Weekly, 2023, 1944 (1) : 104 - 104
[4] Antineoplastics toxicitySuicide: 4 case reports
Reactions Weekly, 2021, 1838 (1) : 65 - 65
[5] Antineoplastics/epirubicinAlopecia: 20 case reports
Reactions Weekly, 2016, 1591 (1) : 30 - 30
[6] Antineoplastics/pegfilgrastimAortitis: 18 case reports
Reactions Weekly, 2023, 1963 (1) : 85 - 85
[7] Antineoplastics/isoniazidHepatotoxicity: 8 case reports
Reactions Weekly, 2022, 1909 (1) : 81 - 81
[8] Antineoplastics/mesnaHypertriglyceridaemia: 2 case reports
Reactions Weekly, 2016, 1630 (1) : 22 - 22
[9] Antineoplastics/dactinomycin/granulocyte colony-stimulating factorsSecondary cancers?: 12 case reports
Reactions Weekly, 2009, 1238 (1) : 5 - 6
[10] Antineoplastics/iodine-125Myelosuppression, ineffectiveness and lack of efficacy: 12 case reports
Reactions Weekly, 2023, 1954 (1) : 73 - 73

← 1 2 3 4 5 →